Skip to content
healthcare.dev

Insulin Glargine

NDC 83257-015, insulin Glargine-yfgn, injection, solution, from Biocon Biologics Inc..

Product NDC
83257-015
Status
Listed
Labeler
Biocon Biologics Inc.
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761201
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83257-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • INSULIN GLARGINE100 [iU]/mL

Pharmacologic classes

Insulin Analog [EPC]; Insulin [CS]

Package NDCNDC-11Package
83257-015-31832570015311 SYRINGE in 1 CARTON (83257-015-31) / 3 mL in 1 SYRINGE
83257-015-32832570015325 SYRINGE in 1 CARTON (83257-015-32) / 3 mL in 1 SYRINGE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/3ac85ebb-5594-59c8-77fd-df254329d151
  • NADAC price for package 83257001532

    GET /v1/drugs/nadac/83257001532

Use it

Look up 83257-015 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83257-015 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83257-015. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.